News
HC Wainwright & Co. Reiterates Buy on Silence Therapeutics, Maintains $75 Price Target
15 Mar 24
News, Price Target, Reiteration, Analyst Ratings
These Analysts Boost Their Forecasts On Silence Therapeutics After Full Year 2023 Results
14 Mar 24
Earnings, News, Price Target, Small Cap, Markets, Analyst Ratings, Trading Ideas
Morgan Stanley Maintains Overweight on Silence Therapeutics, Raises Price Target to $45
14 Mar 24
News, Price Target, Analyst Ratings
Chardan Capital Maintains Buy on Silence Therapeutics, Raises Price Target to $42
14 Mar 24
News, Price Target, Analyst Ratings
What 4 Analyst Ratings Have To Say About Silence Therapeutics
13 Mar 24
Analyst Ratings
HC Wainwright & Co. Maintains Buy on Silence Therapeutics, Maintains $75 Price Target
13 Mar 24
News, Price Target, Analyst Ratings
What's Going On With Silence Therapeutics Stock Today?
13 Mar 24
Equities, News, Markets, Movers, General
Silence Therapeutics Reported 2023 Revenue of £25.4M, EPS Loss of £(38.9), Cash Balance of £54.0M
13 Mar 24
Earnings, News
Silence Therapeutics Announces Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
13 Mar 24
News
Earnings Scheduled For March 13, 2024
13 Mar 24
Earnings
Earnings Scheduled For March 12, 2024
12 Mar 24
Earnings
Silence Therapeutics Achieves $10M Milestone Payment From AstraZeneca Collaboration Following The Initiation Of Phase 1 Trial
23 Feb 24
Biotech, News, Contracts, General
HC Wainwright & Co. Reiterates Buy on Silence Therapeutics, Maintains $75 Price Target
22 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday
31 Jan 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
BMO Capital Initiates Coverage On Silence Therapeutics with Outperform Rating, Announces Price Target of $67
31 Jan 24
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Silence Therapeutics, Maintains $75 Price Target
18 Jan 24
News, Price Target, Reiteration, Analyst Ratings
Press releases
Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
13 Mar 24
Press Releases
Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
13 Mar 24
Press Releases
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
23 Feb 24
Press Releases
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
5 Feb 24
Press Releases
Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31 Jan 24
Press Releases
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
17 Jan 24
Biotech, M&A, News, Management, Press Releases, General